1Y Close · As of Aug 26, 2026
BL Pharmtech operates in the Wholesale Trade sector.
Legal name: BL Pharmtech Corp.
In fiscal year 2025, BL Pharmtech (065170) reported revenue of 6.5 billion KRW, down 26.1% from 8.8 billion KRW a year earlier.
Operating profit was -2.8 billion KRW and net income was -16.8 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 52.0 billion KRW, with a P/B of 6.56.
These figures can be verified in the DART filing (receipt no. 20260324000004).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 6.5B | -2.8B | -16.8B |
| 2024 | 8.8B | -3.2B | -5.7B |
| 2023 | 24.5B | -6.8B | 142M |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |